XML 32 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net loss $ (76,810) $ (35,252) $ (13,932)
Adjustments to reconcile net loss to cash flows (used in) provided by operating activities:      
Depreciation and amortization of property and equipment 11,200 8,486 7,970
Amortization of intangible assets 49,723 17,112 7,500
Stock-based compensation 11,072 25,657 19,768
Impairment of intangible assets 0 5,471 0
Deferred income taxes 513 (20,361) 1,088
Other 4,611 (1,340) (1,265)
Changes in operating assets and liabilities:      
Accounts receivable (13,017) (30,759) (851)
Inventory 993 5,786 4,858
Other operating assets 5,036 269 506
Accounts payable (6,057) 13,415 (821)
Accrued expenses and other long-term liabilities (13,422) (4,263) (7,778)
Deferred revenue 16,563 23,859 2,149
Net cash (used in) provided by operating activities (9,595) 8,080 19,192
Cash flows from investing activities:      
Purchases of property and equipment (7,907) (3,999) (4,626)
Business acquisitions, net of cash acquired (46,389) (42,951) (20,669)
Purchases of marketable securities 0 (28,731) (78,528)
Sale/maturities of marketable securities 18,919 96,112 75,178
Proceeds from the sale of intangible assets 0 576 1,298
Net cash (used in) provided by investing activities (35,377) 21,007 (27,347)
Cash flows from financing activities:      
Borrowings under revolving line of credit 197,500 15,500 0
Principal payments on revolving line of credit (162,500) (13,500) 0
Principal payments of capital lease obligations (652) (99) (43)
Payment of debt issuance costs (624) (731) 0
Proceeds from the sale of common stock in connection with employee stock purchase plan 0 1,252 1,360
Proceeds from the exercise of stock options 73 617 153
Payment of tax withholding obligations related to net share settlements of restricted stock awards (2,024) (7,523) (1,810)
Repurchase of common stock 0 0 (9,530)
Net cash provided by (used in) financing activities 31,773 (4,484) (9,870)
Effect of exchange rate changes on cash and cash equivalents (180) 547 (163)
Net (decrease) increase in cash and cash equivalents (13,379) 25,150 (18,188)
Cash and cash equivalents, beginning of year 57,073 31,923 50,111
Cash and cash equivalents, end of period 43,694 57,073 31,923
Supplemental disclosure of cash flow information:      
Interest paid 2,367 317 41
Income taxes paid 5,505 2,290 1,249
Income tax refunds received 537 274 511
Supplemental disclosure of non-cash investing activities:      
Capital expenditures incurred, but not yet paid 1,127 1,043 277
Property and equipment acquired under capital lease 2,178 0 36
Business acquisition purchase consideration - common stock issued 30,000 413,982 0
Business acquisition purchase consideration - deferred payments 30,000 0 0
Business acquisition purchase consideration - note issued to selling equity holders 0 22,500 0
Business acquisition purchase consideration - assumed equity awards 747 0 0
Supplemental disclosure of non-cash financing activities:      
Total fair value of restricted stock awards, restricted stock units, performance-based stock awards and performance-based stock units on date vested $ 8,312 $ 20,515 $ 10,376